ArticleCancers2025

Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?

Sarah E Glynn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.